Interplay of Sps and poly(C) binding protein 1 on the μ-opioid receptor gene expression

Biochemical and Biophysical Research Communications

Volumn 345, Issue 1, 2006, Pages 530-537

  Rivera Gines, Aida ^a   Cook, Ryan J ^a   Loh, Horace H ^b   Ko, Jane L ^a  

^a SETON HALL UNIVERSITY   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Chromatin immunoprecipitation; Functional interplay; MOR gene expression; Poly(C) binding protein 1; Sp1; Sp3

Indexed keywords

BINDING PROTEIN; MU OPIATE RECEPTOR; POLY(C) BINDING PROTEIN 1; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP3; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING;

ANIMALS; CELLS, CULTURED; DROSOPHILA; GENE EXPRESSION; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS; PROTEIN BINDING; RECEPTORS, OPIOID, MU; SP1 TRANSCRIPTION FACTOR; SP3 TRANSCRIPTION FACTOR;

ANIMALIA;

EID: 33646415116     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.04.117     Document Type: Article

References (42)

1. Kieffer B.L., and Evan C.L. Opioid tolerance-in search of the holy grail. Cell 108 (2002) 587-590
2. Law P.Y., Loh H.H., and Wei L.N. Insight into the receptor transcription and signaling: implications in opioid tolerance and dependence. Neuropharmacology 47 (2004) 300-311
3. Van Ree J.M., Gerrits M., and Vanderschuren L. Opioids, reward and addiction: an encounter of biology, psychology, and medicine. Pharmacol. Rev. 51 (1999) 341-396
4. Law P.Y., and Loh H.H. Regulation of opioid receptor activities. J. Pharmacol. Exp. Ther. 289 (1999) 607-624
5. Kieffer B.L., and Gaveriaux-Ruff C. Exploring the opioid system by gene knockout. Prog. Neurobiol. 66 (2002) 285-306
6. Mansour A., Fox C.A., Akil H., and Watson S.J. Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci. 18 (1995) 22-29
7. Min B.H., Augustin L.B., Felsheim J.A., Fuchs J.A., and Loh H.H. Genomic structure and analysis of promoter sequence of a mouse μ opioid receptor gene. Proc. Natl. Acad. Sci. USA 91 (1994) 9081-9085
8. Pan Y.X., Xu J., Mahurter L., Bolan E., Xu M., and Pasternak G.W. Generation of the mu opioid receptor (MOR-1) protein by three new splice variants of the Oprm gene. Proc. Natl. Acad. Sci. USA 98 (2001) 14084-14089
9. Ko J.L., Minnerath S.R., and Loh H.H. Dual promoters of mouse mu-opioid receptor gene. Biochem. Biophys. Res. Commun. 234 (1997) 351-357
10. Ko J.L., Chen H.C., and Loh H.H. Differential promoter usage of mouse mu-opioid receptor gene during development. Mol. Brain Res. 104 (2002) 184-193
11. Law P.Y., Loh H.H., and Wei L.N. Insights into the receptor transcription and signaling: implications in opioid tolerance and dependence. Neuropharmacology 47 (2004) 300-311
12. Ko J.L., Liu H.C., Minnerath S.R., and Loh H.H. Transcriptional regulation of mouse mu-opioid receptor gene. J. Biol. Chem. 273 (1998) 27678-27685
13. Ko J.L., Liu H.C., and Loh H.H. Role of an AP-2-like element in transcriptional regulation of mouse mu-opioid receptor gene. Mol. Brain Res. 112 (2003) 153-162
14. Ko J.L., and Loh H.H. Single-stranded DNA-binding complex involved in transcriptional regulation of mouse mu-opioid receptor gene. J. Biol. Chem. 276 (2001) 788-795
15. Ko J.L., and Loh H.H. Poly C binding protein, a single-stranded DNA binding protein, regulates mouse mu-opioid receptor gene expression. J. Neurochem. 93 (2005) 749-761
16. Suske G. The Sp-family of transcription factors. Gene 238 (1999) 291-300
17. Bouwman P., and Philipsen S. Regulation of the activity of Sp1-related transcription factors. Mol. Cell. Endocrinol. 195 (2002) 27-38
18. Roder K., Wolf S.S., Larkin K.J., and Schweizer M. Interaction between the two ubiquitously expressed transcription factors NF-Y and Sp1. Gene 234 (1999) 61-69
19. Courey A., and Tijan R. In: McKnight S., and Yamamoto K. (Eds). Transcription Regulation (1992), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY 743-769
20. Legget R.W., Armstrong S.A., Barry D., and Mueller C.R. Sp1 is phosphorylated and its DNA binding activity down-regulated upon terminal differentiation of the liver. J. Biol. Chem. 270 (1995) 25879-25884
21. Black A.R., Jensen D., Lin S.Y., and Azizkhan C. Growth/cell cycle regulation of Sp1 phosphorylation. J. Biol. Chem. 274 (1999) 1207-1215
22. Saffer J.D., Jackson S.P., and Annarella M.B. Developmental expression of Sp1 in the mouse. Mol. Cell. Biol. 11 (1991) 2189-2199
23. Noe V., Alemany C., Nicolas M., and Ciudad C.J. Sp1 involvement in the 4β-phorbol 12-myristate 13-acetate (TPA)-mediated increase in resistance to methotrexate in chinese hamster ovary cells. Eur. J. Biochem. 268 (2001) 3163-3173
24. Denning J., Beato M., and Suske G. An inhibitor domain in Sp3 regulates its glutamine-rich activation domains. EMBO J. 15 (1996) 5659-5667
25. Sjottem E., Aderssen S., and Johansen T. The promoter activity of long terminal repeats of the HERV-H family of human retrovirus-like elements is critically dependent on Sp1 family proteins interacting with a GC/GT box located immediately 3′ to the TATA box. J. Virol. 70 (1996) 188-198
26. Birnbaum M.J., Van Wijnen A.J., Odgren P., Last T.J., Suske G., Stein G., and Stein J. Sp1 trans-activation of cell cycle regulated promoters is selectively repressed by Sp3. Biochemistry 34 (1995) 16503-16508
27. Sapetschnig A., Koch F., Rischitor G., Mennenga T., and Suske G. Complexity of translationally controlled transcription factor Sp3 isoform expression. J. Biol. Chem. 279 (2004) 42095-42105
28. Ammanamanchi S., Freeman J.W., and Brattain M.G. Acetylated Sp3 is a transcriptional activator. J. Biol. Chem. 278 (2003) 35775-35780
29. Kim S.S., Pandey K.K., Choi H.S., Law P.Y., Wei L.N., and Loh H.H. Poly C binding protein family is a transcription factor in mu-opioid receptor gene expression. Mol. Pharm. 68 (2005) 729-736
30. Denisenko O., and Bomsztyk K. Yeast hnRNP K-like genes are involved in regulation of the telomeric position effect and telomere length. Mol. Cell. Biol. 22 (2002) 286-297
31. Michelotti E.F., Michelotti G.A., Aronsohn A.I., and Levens D. Heterogeneous nuclear ribonucleoprotein K is a transcription factor. Mol. Cell. Biol. 16 (1996) 2350-2360
32. Expert-Bezancon A., P Le Caer J., and Marie J. Heterogeneous nuclear ribonucleoprotein (hnRNP) K is a component of an intronic splicing enhancer complex that activates the splicing of the alternative exon 6A from chicken beta-tropomyosin pre-mRNA. J. Biol. Chem. 277 (2002) 16614-16623
33. Ostareck-Lederer A., Ostareck D.H., Cans C., Neubauer G., Bomsztyk K., Superti-Furga G., and Hentze M.W. c-Src-mediated phosphorylation of hnRNP K drives translational activation of specifically silenced mRNAs. Mol. Cell. Biol. 22 (2002) 4535-4543
34. Conn K.J., Rich C.B., Jenson D.E., Fontanilla M.R., Bashir M.M., Rosenbloom J., and Foster J.A. Insulin-like growth factor-I regulates transcription of the elastin gene through a putative retinoblastoma control element. A role for Sp3 acting as a repressor of elastin gene transcription. J. Biol. Chem. 271 (1996) 28853-28860
35. Gill G., and Tjian R. Eukaryotic coactivators associated with the TATA box binding protein. Curr. Opin. Genet. Dev. 2 (1992) 236-242
36. Zhang Y., and Dufau M.L. Repression of the luteinizing hormone receptor gene promoter by cross talk among EAR3/COUP-TFI, Sp1/Sp3, and TFIIB. Mol. Cell. Biol. 23 (2003) 6958-6972
37. Du Q., Melnikova I.N., and Gardner P.D. Differential effects of heterogeneous nuclear ribonucleoprotein K on Sp1- and Sp3-mediated transcriptional activation of a neuronal nicotinic acetylcholine receptor promoter. J. Biol. Chem. 273 (1998) 19877-19883
38. Denisenko O.N., O'Neill B., Ostrowski J., Van Seuningen I., and Bomsztyk K. Zik1, a transcriptional repressor that interacts with the heterogeneous nuclear ribonucleoprotein particle K protein. J. Biol. Chem. 271 (1996) 27701-27706
39. Thompson P.R., Wang D., Wang L., Fulco M., Pediconi N., Zhang D., An W., Ge Q., Roeder R.G., Wong J., Levrero M., Sartorelli V., Cotter R.J., and Cole P.A. Regulation of the p300 HAT domain via a novel activation loop. Nat. Struct. Mol. Biol. 11 (2004) 308-315
40. Ammanamanchi S., Freeman J.W., and Brattain M.G. Acetylated Sp3 is a transcriptional activator. J. Biol. Chem. 278 (2003) 35775-35780
41. Selley D.E., Sim L.J., Xiao R., Liu Q., and Childers S.R. mu-Opioid receptor-stimulated guanosine-5′-O-(gamma-thio)-triphosphate binding in rat thalamus and cultured cell lines: signal transduction mechanisms underlying agonist efficacy. Mol. Pharmacol. 51 (1997) 87-96
42. Nestler E.J. Historical review: molecular and cellular mechanisms of opiate and cocaine addiction. Trends Pharmacol. Sci. 25 (2004) 210-218